RSSL (Reading Scientific Services) operates across two major industry verticals, providing contract laboratory and scientific services to clients in life sciences and pharmaceuticals as well as food and consumer goods. Based in Reading, UK, the organisation positions itself as an outsourced testing and innovation partner covering everything from early research and discovery through to manufacturing, commercialisation, and regulatory compliance.
Within the pharmaceutical and life science sector, RSSL offers testing across a broad range of molecule and product types, including biologics, cell and gene therapy, consumer healthcare, small molecule pharmaceuticals, vaccines, veterinary medicine, and specialised nutritional products. Services are organised by development phase, allowing clients to engage at preclinical stages, through clinical development, and into commercial-scale manufacturing. Capabilities span pharmacopoeial testing, ICH stability studies, contamination and impurity analysis, microbiology testing, and a rapid mycoplasma screening and detection service, which the company describes as fast, compliant, and sensitive. A priority response service is also available for time-critical projects.
RSSL maintains an Innovation Hub and a dedicated services directory spanning techniques and methods to support product development across its client base. The food and consumer goods division extends these analytical capabilities into food and beverages, ingredients, consumer goods, food service, specialised nutrition, nutraceuticals, and dietary supplements. A recently announced dedicated nutritional testing service, supported by a £1.2 million investment, reflects continued capital commitment to expanding laboratory capacity in this area.
Further information is available at rssl.com.